Greece vs Trinidad and Tobago: The number of people with susceptibility test result for rifampicin
Greece
55
in 2021
Trinidad and Tobago
57
in 2021
Greece rank
121st
Trinidad and Tobago rank
120th
The number of people with susceptibility test result for rifampicin over time
- Greece
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 57 against 55 in Greece, a difference of 2.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Greece ahead.
Greece ranks 121st and Trinidad and Tobago ranks 120th of 155 countries.
Greece has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Greece | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 149.33 | 102.67 | 46.67 | Greece |
| 2020s | 159 | 74.5 | 84.5 | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Greece or Trinidad and Tobago?
- Trinidad and Tobago, at 57 against 55 in Greece as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Greece and Trinidad and Tobago?
- 2, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Greece and Trinidad and Tobago?
- 5 years are reported by both, from 2017 to 2021.
- How do Greece and Trinidad and Tobago rank globally for the number of people with susceptibility test result for rifampicin?
- Greece ranks 121st and Trinidad and Tobago ranks 120th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.